Amylyx Pharmaceuticals | 8-K:重大事件
Amylyx Pharmaceuticals | SC 13G/A:超過5%持股股東披露文件(修正)-BlackRock, Inc.(3.9%)
Amylyx Pharmaceuticals | 8-K:重大事件
Amylyx Pharmaceuticals | 4:持股變動聲明-董事 FONTEYNE PAUL R.
Amylyx Pharmaceuticals | 4:持股變動聲明-董事 Firestone Karen
Amylyx Pharmaceuticals | 4:持股變動聲明-董事 Zeiher Bernhardt G
Amylyx Pharmaceuticals | 4:持股變動聲明-董事 MILNE GEORGE M JR
Amylyx Pharmaceuticals | 4:持股變動聲明-董事 Quimi Daphne
Amylyx Pharmaceuticals | 8-K:重大事件
Amylyx Pharmaceuticals | 4:持股變動聲明-董事 Quimi Daphne
Amylyx Pharmaceuticals | 4:持股變動聲明-高管 Mazzariello Gina
Amylyx Pharmaceuticals | 144:擬議出售證券
Amylyx Pharmaceuticals | 10-Q:季度報表
Amylyx Pharmaceuticals | 8-K:Amylyx 製藥公佈2024年第一季度財務業績
Amylyx Pharmaceuticals | ARS:年度報告
Amylyx Pharmaceuticals | DEFA14A:其他
Amylyx Pharmaceuticals | DEF 14A:股東委託書決議
Amylyx Pharmaceuticals | 4:持股變動聲明-高管 FRATES JAMES M
Amylyx Pharmaceuticals | 4:持股變動聲明-高管 Cohen Joshua B
Amylyx Pharmaceuticals | 4:持股變動聲明-高管 Mazzariello Gina
暫無數據